BioBio ApS: Financial statements 2025
CVR: 42187542
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
BioBio ApS (CVR 42187542) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK -25,354 and a net result of DKK -20,224 compared with DKK -21,169 the year before. Equity in the 2025 report amounted to DKK 166,288. The solvency ratio was 77.4%.
- Gross Profit
- DKK -25,354
- Profit/Loss
- DKK -20,224
- Equity
- DKK 166,288
- Total Assets
- DKK 214,971
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | -25K | -20K | 166K | - |
| 2024 | - | -22K | -21K | 187K | - |
| 2023 | - | 9K | 5K | 208K | - |
| 2022 | - | 113K | 87K | 202K | - |
| 2021 | - | 107K | 75K | 115K | - |
Official annual report
How creditworthy is BioBio ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
BioBio ApS has published its annual report for 2024. Gross profit came to DKK -21,544, and the net result was DKK -21,169.
About BioBio ApS
BioBio ApS is a Danish company of the type Anpartsselskab based in København K, founded in 2021. The company is registered under the industry Industrielt design og modedesign. The management consists of Katrine Helt Schaarup. The company is owned by Twenty/Twenty ApS. In 2025, the company reported a gross profit of DKK -25,354 and a net result of DKK -20,224 compared with DKK -21,169 the year before. Equity in the 2025 report amounted to DKK 166,288.